| Ytd | -31.89% | |
| 1y | -71.57% |
| Open | 0.67 | Prev Close | 0.67 | Low | 0.64 | High | 0.68 | Mkt Cap | 112.69M |
| Vol | 4.46M | Avg Vol | 10.56M | EPS | -0.60 | P/E | -1.12 | Forward P/E | -5.41 |
| Beta | 2.52 | Short Ratio | 6.37 | Inst. Own | 30.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 0.96 | 200-d Avg | 1.10 | 1yr Est | 13.71 |
HUMA News
In the latest trading session, Humacyte, Inc. (HUMA) closed at $0.67, marking a +2.22% move from the
Humacyte, Inc. (HUMA) closed at $0.66 in the latest trading session, marking a -1.28% move from the
Humacyte, Inc. (HUMA) closed the most recent trading day at $0.71, moving +2.31% from the previous t
- Dr. Robert J. Kossmann has served as a prominent advocate for kidney disease patients in multiple
Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T
The latest trading day saw Humacyte, Inc. (HUMA) settling at $0.78, representing a -2.32% change fro
Humacyte, Inc. (HUMA) concluded the recent trading session at $0.62, signifying a -11.14% move from
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations
Humacyte, Inc. (HUMA) closed the most recent trading day at $1.03, moving 3.74% from the previous tr
Humacyte, Inc. (HUMA) Discusses V012 Study Top-Line Results for Engineered Vessel in Dialysis Access
Humacyte, Inc. (HUMA) might move higher on growing optimism about its earnings prospects, which is r
– Positive results from the V012 Phase 3 study were presented at the Society for Vascular Surgery's
DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage bi
DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage bi
- Humacyte plans to file a supplemental Biologic License Application (BLA) with the Food and Drug Ad
Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, Jun
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations
- Dialysis access requires frequent cannulation, often exceeding 300 needle punctures annually - -
- Surgical Implant – Next Generation contract makes Symvess more easily accessible to 170 VA hospita
Top Wall Street analysts changed outlook on top names. Needham downgrades CNTA, Baird downgrades PHR
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q
On Thursday, 241 companies hit new 52-week lows.
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media S
On Thursday, 588 stocks hit new 52-week lows.
On Wednesday, 329 companies hit new 52-week lows.
On Tuesday, 951 companies hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
On Monday, 198 companies reached new 52-week lows.